PFPT
IBB icon

Pinnacle Financial Partners (Tennessee)’s iShares Biotechnology ETF IBB Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$352K Buy
2,440
+40
+2% +$5.46K 0.01% 376
2025
Q2 		$304K Hold
2,400
– – 0.01% 386
2025
Q1 		$307K Sell
2,400
-285
-11% -$38.6K 0.01% 379
2024
Q4 		$355K Buy
2,685
+60
+2% +$8.44K 0.01% 360
2024
Q3 		$382K Hold
2,625
– – 0.01% 352
2024
Q2 		$360K Hold
2,625
– – 0.01% 355
2024
Q1 		$360K Sell
2,625
-416
-14% -$56.8K 0.01% 354
2023
Q4 		$413K Buy
3,041
+41
+1% +$5K 0.01% 325
2023
Q3 		$367K Hold
3,000
– – 0.01% 321
2023
Q2 		$381K Hold
3,000
– – 0.01% 323
2023
Q1 		$387K Buy
3,000
+375
+14% +$49.1K 0.01% 322
2022
Q4 		$345K Sell
2,625
-450
-15% -$58.2K 0.01% 321
2022
Q3 		$360K Hold
3,075
– – 0.01% 301
2022
Q2 		$362K Buy
3,075
+450
+17% +$53.4K 0.01% 296
2022
Q1 		$342K Hold
2,625
– – 0.01% 307
2021
Q4 		$401K Hold
2,625
– – 0.01% 308
2021
Q3 		$424K Sell
2,625
-36
-1% -$6.06K 0.01% 293
2021
Q2 		$435K Sell
2,661
-28
-1% -$4.31K 0.02% 278
2021
Q1 		$405K Sell
2,689
-22
-0.8% -$3.49K 0.02% 269
2020
Q4 		$411K Sell
2,711
-22
-0.8% -$3.14K 0.02% 271
2020
Q3 		$370K Buy
2,733
+22
+0.8% +$2.98K 0.02% 264
2020
Q2 		$371K Buy
2,711
+50
+2% +$6.37K 0.02% 257
2020
Q1 		$287K Hold
2,661
– – 0.02% 279
2019
Q4 		$321K Hold
2,661
– – 0.02% 299
2019
Q3 		$265K Hold
2,661
– – 0.02% 301
2019
Q2 		$290K Hold
2,661
– – 0.02% 286
2019
Q1 		$298K Buy
2,661
+36
+1% +$3.95K 0.02% 282
2018
Q4 		$253K Sell
2,625
-1,657
-39% -$176K 0.02% 284
2018
Q3 		$522K Buy
4,282
+1,357
+46% +$160K 0.04% 232
2018
Q2 		$321K Sell
2,925
-217
-7% -$23.2K 0.03% 254
2018
Q1 		$335K Buy
3,142
+57
+2% +$6.32K 0.03% 244
2017
Q4 		$329K Buy
3,085
+10
+0.3% +$1.07K 0.03% 244
2017
Q3 		$342K Buy
+3,075
New +$329K 0.04% 219

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s IBB Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) increased its iShares Biotechnology ETF (IBB) stake by 1.7% in Q3 2025, buying an estimated $5.46K and bringing the position to 2,440 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #376.

Pinnacle Financial Partners (Tennessee) first reported a position in IBB in Q3 2017 and has held it in 33 quarters since. The position peaked at $522K in Q3 2018. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Pinnacle Financial Partners (Tennessee) held 2,440 shares of iShares Biotechnology ETF worth $352K as of Q3 2025.
  • Pinnacle Financial Partners (Tennessee) bought 40 iShares Biotechnology ETF shares in Q3 2025, an estimated $5.46K.
  • iShares Biotechnology ETF made up 0.01% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #376 holding.
  • Pinnacle Financial Partners (Tennessee) first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 33 quarters since.
  • Pinnacle Financial Partners (Tennessee)'s iShares Biotechnology ETF position peaked at $522K in Q3 2018.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.